Go Pro
→ Why I believe the AI market will split in Q4 (From The Oxford Club) (Ad)tc pixel Free IMAC Stock Alerts

IMAC (IMAC) Competitors

IMAC logo
$0.0006 0.00 (0.00%)
As of 09/22/2026
Compare

IMAC vs. BACK, AONCW, BTSGU, LFMDP, and NIVFW

Should you buy IMAC stock or one of its competitors? IMAC's main competitors and comparable companies include IMAC (BACK), American Oncology Network (AONCW), BrightSpring Health Services (BTSGU), LifeMD (LFMDP), and NewGenIvf Group (NIVFW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare providers & services" industry.

How does IMAC compare to IMAC?

IMAC (NASDAQ:BACK) and IMAC (NASDAQ:IMAC) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, institutional ownership, media sentiment, risk, dividends, analyst recommendations, profitability and earnings.

5.8% of IMAC shares are owned by institutional investors. Comparatively, 24.3% of IMAC shares are owned by institutional investors. 12.3% of IMAC shares are owned by insiders. Comparatively, 10.0% of IMAC shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, IMAC had 1 more articles in the media than IMAC. MarketBeat recorded 1 mentions for IMAC and 0 mentions for IMAC. IMAC's average media sentiment score of 0.14 beat IMAC's score of 0.00 indicating that IMAC is being referred to more favorably in the news media.

Company Overall Sentiment
IMAC Neutral
IMAC Neutral

IMAC has higher earnings, but lower revenue than IMAC. IMAC is trading at a lower price-to-earnings ratio than IMAC, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IMAC$72.05K0.03-$9.42M-$3.12N/A
IMAC$15.22M0.00-$10.54M-$0.27N/A

IMAC has a beta of 1.98, suggesting that its share price is 98% more volatile than the broader market. Comparatively, IMAC has a beta of -0.88, suggesting that its share price is 188% less volatile than the broader market.

IMAC has a net margin of 0.00% compared to IMAC's net margin of -75.40%. IMAC's return on equity of 0.00% beat IMAC's return on equity.

Company Net Margins Return on Equity Return on Assets
IMACN/A N/A -325.44%
IMAC -75.40%-52.17%-34.51%

Summary

IMAC beats IMAC on 7 of the 13 factors compared between the two stocks.

How does IMAC compare to American Oncology Network?

IMAC (NASDAQ:IMAC) and American Oncology Network (NASDAQ:AONCW) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, dividends, analyst recommendations, profitability, valuation, risk and media sentiment.

American Oncology Network has a net margin of 0.00% compared to IMAC's net margin of -75.40%. American Oncology Network's return on equity of 0.00% beat IMAC's return on equity.

Company Net Margins Return on Equity Return on Assets
IMAC-75.40% -52.17% -34.51%
American Oncology Network N/A N/A N/A

American Oncology Network has higher revenue and earnings than IMAC.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IMAC$15.22M0.00-$10.54M-$0.27N/A
American Oncology Network$1.34BN/AN/AN/AN/A

24.3% of IMAC shares are held by institutional investors. 10.0% of IMAC shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, IMAC had 1 more articles in the media than American Oncology Network. MarketBeat recorded 1 mentions for IMAC and 0 mentions for American Oncology Network. IMAC's average media sentiment score of 0.14 beat American Oncology Network's score of 0.00 indicating that IMAC is being referred to more favorably in the media.

Company Overall Sentiment
IMAC Neutral
American Oncology Network Neutral

Summary

IMAC and American Oncology Network tied by winning 4 of the 8 factors compared between the two stocks.

How does IMAC compare to BrightSpring Health Services?

BrightSpring Health Services (NASDAQ:BTSGU) and IMAC (NASDAQ:IMAC) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, valuation, media sentiment, dividends, profitability, analyst recommendations, institutional ownership and risk.

In the previous week, IMAC had 1 more articles in the media than BrightSpring Health Services. MarketBeat recorded 1 mentions for IMAC and 0 mentions for BrightSpring Health Services. IMAC's average media sentiment score of 0.14 beat BrightSpring Health Services' score of 0.00 indicating that IMAC is being referred to more favorably in the news media.

Company Overall Sentiment
BrightSpring Health Services Neutral
IMAC Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BrightSpring Health Services
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
IMAC
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

BrightSpring Health Services has higher revenue and earnings than IMAC.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BrightSpring Health Services$14.37BN/AN/AN/AN/A
IMAC$15.22M0.00-$10.54M-$0.27N/A

24.3% of IMAC shares are held by institutional investors. 10.0% of IMAC shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

BrightSpring Health Services has a net margin of 0.00% compared to IMAC's net margin of -75.40%. BrightSpring Health Services' return on equity of 0.00% beat IMAC's return on equity.

Company Net Margins Return on Equity Return on Assets
BrightSpring Health ServicesN/A N/A N/A
IMAC -75.40%-52.17%-34.51%

Summary

BrightSpring Health Services beats IMAC on 5 of the 9 factors compared between the two stocks.

How does IMAC compare to LifeMD?

LifeMD (NASDAQ:LFMDP) and IMAC (NASDAQ:IMAC) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, dividends, profitability, analyst recommendations, valuation, risk, institutional ownership and media sentiment.

In the previous week, LifeMD had 1 more articles in the media than IMAC. MarketBeat recorded 2 mentions for LifeMD and 1 mentions for IMAC. LifeMD's average media sentiment score of 0.50 beat IMAC's score of 0.14 indicating that LifeMD is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LifeMD
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
IMAC
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

LifeMD has higher revenue and earnings than IMAC.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LifeMD$191.59MN/AN/AN/AN/A
IMAC$15.22M0.00-$10.54M-$0.27N/A

24.3% of IMAC shares are held by institutional investors. 10.0% of IMAC shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

LifeMD has a net margin of 0.00% compared to IMAC's net margin of -75.40%. LifeMD's return on equity of 0.00% beat IMAC's return on equity.

Company Net Margins Return on Equity Return on Assets
LifeMDN/A N/A N/A
IMAC -75.40%-52.17%-34.51%

Summary

LifeMD beats IMAC on 6 of the 8 factors compared between the two stocks.

How does IMAC compare to NewGenIvf Group?

IMAC (NASDAQ:IMAC) and NewGenIvf Group (NASDAQ:NIVFW) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, valuation, risk, media sentiment and profitability.

24.3% of IMAC shares are held by institutional investors. 10.0% of IMAC shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

NewGenIvf Group has a net margin of 0.00% compared to IMAC's net margin of -75.40%. NewGenIvf Group's return on equity of 0.00% beat IMAC's return on equity.

Company Net Margins Return on Equity Return on Assets
IMAC-75.40% -52.17% -34.51%
NewGenIvf Group N/A N/A N/A

NewGenIvf Group has lower revenue, but higher earnings than IMAC.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IMAC$15.22M0.00-$10.54M-$0.27N/A
NewGenIvf Group$4.73MN/AN/AN/AN/A

In the previous week, IMAC had 1 more articles in the media than NewGenIvf Group. MarketBeat recorded 1 mentions for IMAC and 0 mentions for NewGenIvf Group. IMAC's average media sentiment score of 0.14 beat NewGenIvf Group's score of 0.00 indicating that IMAC is being referred to more favorably in the media.

Company Overall Sentiment
IMAC Neutral
NewGenIvf Group Neutral

Summary

IMAC beats NewGenIvf Group on 5 of the 8 factors compared between the two stocks.

Get IMAC News Delivered to You Automatically

Sign up to receive the latest news and ratings for IMAC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IMAC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IMAC vs. The Competition

Export
MetricIMACHealthcare Providers & Services IndustryHealthcare SectorNASDAQ Exchange
Market Cap$16K$9.77B$7.31B$13.29B
Dividend YieldN/A2.61%2.52%12.57%
P/E Ratio0.0034.44274.0725.69
Price / Sales0.004.86643.1379.17
Price / CashN/A122.1177.8052.76
Price / Book0.005.2010.476.32
Net Income-$10.54M$315.70M$3.49B$359.73M
7 Day PerformanceN/A-1.49%-0.67%0.17%
1 Month PerformanceN/A-1.93%-3.17%-3.27%
1 Year PerformanceN/A13.31%15.13%5.58%

IMAC Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IMAC
IMAC
N/A$0.00
flat		N/A-99.2%$16K$15.22MN/A106
BACK
IMAC
N/A$0.00
flat		N/A-99.3%$2K$72.05KN/A180
AONCW
American Oncology Network
N/A$0.00
flat		N/AN/A$0.00$1.34BN/A1,525
BTSGU
BrightSpring Health Services
N/A$187.60
+0.2%		N/A+91.5%$0.00$14.37BN/A35,000
LFMDP
LifeMD
N/A$23.36
+0.9%		N/A-2.9%$0.00$191.59MN/A230

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:IMAC) was last updated on 9/24/2026 by MarketBeat.com Staff.
From Our Partners
How to get a stake in Anthropic — before the IPO
Anthropic, the maker of Claude AI, has reportedly filed for an IPO that could arrive as early as October. Its ...
Weiss Ratings | Sponsoredtc pixel
Why I believe the AI market will split in Q4
Matt McCall, who recommended Nvidia near $6 a share, says the AI market is splitting in two - just like the do...
The Oxford Club | Sponsoredtc pixel
Shocking new footage just released
Gerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...
Digest Publishing | Sponsoredtc pixel
Barricks gold output fell from 2 million ounces to 719000
Barrick's gold production has plunged from 2 million ounces to just 719,000, leaving the world's second-larges...
Golden Portfolio | Sponsoredtc pixel
Major Buy Alert Issued for September 30th
Keith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...
TradeSmith | Sponsoredtc pixel
If you keep cash in a U.S. bank account… read this NOW
Since 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...
Banyan Hill Publishing | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...
Porter & Company | Sponsoredtc pixel